RAGHAD LEPLEY: Open Payments
NPI 1093776684 · HIGHLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 98 payments from 21 companies in 2025. Trend: 2023 $2,125 · 2024 $1,272 · 2025 $1,931
Food & beverage: $1,932
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $276 |
| Vanda Pharmaceuticals Inc. | 15 | $275 |
| Indivior Inc. | 11 | $248 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $152 |
| Lilly USA, LLC | 4 | $104 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Lundbeck LLC | 3 | $77 |
| PFIZER INC. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
Products named: FANAPT, SUBLOCADE, XIFAXAN, REXULTI, VRAYLAR, UBRELVY, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
